IP Library › Granted Patent US 7,026,423
Granted Patent B2
US 7,026,423 · App. 10/219,732 · Granted Apr 11, 2006

Silicon-based polycarbonates

Assignee: Aortech Biomaterials Pty Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,026,423
App. No.
10/219,732
Granted
Apr 11, 2006
Kind
B2
Abstract

A silicon-based polycarbonate of formula (I): wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 8 and R 9 are the same or different and selected from hydrogen or an optionally substituted straight chain, branched or cyclic, saturated or unsaturated hydrocarbon radical; R 7 is a divalent linking group or an optionally substituted straight chain, branched or cyclic, saturated or unsaturated by hydrocarbon radical; A is an endcapping group; n, y and z are integers of 0 or more; and x is an integer of 0 or more.

Claims (33)

1. A polyurethane elastomeric composition which includes a silicon-based polycarbonate segment of the formula (Ib):

wherein

R 1 , R 2 , R 3 and R 4 , are the same or different and are hydrogen or an optionally substituted straight chain, branched or cyclic, saturated or unsaturated hydrocarbon radical;

R 5 , R 6 , R 8 and R 9 are the same or different and are a straight chain, branched or cyclic, saturated or unsaturated hydrocarbon radical;

R 7 is a divalent linking group or an optionally substituted straight chain, branched or cyclic, saturated or unsaturated, hydrocarbon radical;

n, y and z are integers of 0 or more; and

x is an integer of 0 or more; provided that z is an integer of 1 or more.

2. A polyurethane elastomeric composition comprising a reaction product of:

wherein

R 1 , R 2 , R 3 and R 4 , are the same or different and are hydrogen or an optionally substituted straight chain, branched or cyclic, saturated or unsaturated hydrocarbon radical;

R 5 , R 6 , R 8 and R 9 are the same or different and are a straight chain, branched or cyclic, saturated or unsaturated hydrocarbon radical;

R 7 is a divalent linking group O, S, NR wherein R is hydrogen or an optionally substituted straight chain, branched or cyclic, saturated or unsaturated, hydrocarbon radical, or an optionally substituted straight chain, branched or cyclic, saturated or unsaturated hydrocarbon radical;

A is an endcapping group;

n, y and z are integers of 0 or more; and

x is an integer of 0 or more; provided that z is an integer of 1 or more;

(ii) a diisocyanate; and

(iii) a chain extender.

3. The polyurethane elastomeric composition as claimed in claim 2 wherein the diisocyanate is selected from 4,4′-methylenediphenyl diisocyanate (MDI), methylene bis (cyclohexyl) diisocyanate (H12MDI), p-phenylene diisocyanate (p-PDI), trans-cyclohexane-1,4-diisocyanate (CHDI) or a mixture of the cis and trans isomers, 1,6-hexamethylene diisocyanate (DICH), 2,4-toluene diisocyanate (2,4-TDI) or its isomers or mixtures thereof; p-tetramethylxylene diisocyanate (p-TMXDI) and m-tetramethylxylene diisocyanate (m-TMXDI).

4. The polyurethane elastomeric composition as claimed in claim 2 wherein the chain extender is selected from 1,4-butanediol, 1,6-hexanediol, 1,8-octanediol, 1,9-nonanediol, 1,10-decanediol 1,4-cyclohexane dimethanol, p-xyleneglycol, 1,4-bis (2-hydroxyethoxy) benzene and 1,12-dodecanediol.

5. A polyurethane elastomeric composition comprising a reaction product of:

(i) a silicon based polycarbonate of the formula (Ia):

wherein R 1 R 2 , R 3 and R 4 are methyl; R 8 is ethyl; R 9 is hexyl; R 5 and R 6 are propyl or butyl; R 7 is O or —CH 2 —CH 2 —; and

n, x and y are integers of 0 or more;

provided z is an integer of 1 or more;

(ii) 4,4′-methylenediphenyl diisocyanate; and

(iii) 1,4-butanediol.

6. A material having improved mechanical properties, clarity, processability and/or degradation resistance comprising a polyurethane elastomeric composition which includes a polycarbonate segment of the formula (Ib) as defined in claim 1 .

7. Medical devices, articles or implants which are composed wholly or partly of the polyurethane elastomeric composition defined in claim 1 .

8. Medical devices, articles or implants of claim 7 wherein said medical devices, articles or implants are cardiac pacemakers, defibrillators, catheters, heart valves, cardiac assist devices, vascular grafts or implantable prostheses.

9. A material having improved mechanical properties; clarity, processability and/or degradation resistance comprising a polyurethane elastomeric composition as defined in claim 1 .

10. Medical devices, articles, or implants of claim 7 wherein said medical devices, articles, or implants are cannulas, extra-corporeal devices, artificial organs, pacemaker leads, defibrillator leads, blood pumps, balloon pumps, A-V shunts, biosensors, membranes for cell encapsulation, drug delivery devices, wound dressings, artificial joints, orthopaedic implants, or soft tissue replacements.

11. A device or article which is composed wholly or partly of the polyurethane elastomeric composition as defined in claim 1 .

12. A device or article according to claim 11 which is selected from artificial leather, shoe soles, cable sheathing, varnishes, coatings, structural components for pumps or vehicles, mining ore screens, conveyor belts, laminating compounds, textiles, separation membranes, sealants, and adhesive components.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 15, 2011
From: AORTECH BIOMATERIALS PTY LTD
To: AORTECH INTERNATIONAL PLC
Reel/Frame 026449/0984 →
ADDRESS CHANGE Recorded Dec 29, 2005
From: AORTECH BIOMATERIALS PTY LTD.
To: AORTECH BIOMATERIALS PTY LTD.
Reel/Frame 017145/0658 →
Priority Claims (1)
AU PO7002 · May 26, 1997 · national
Continuity (2)
Continuation 0942449200
Related Publication 20030092864A1 · May 15, 2003